TAVI: past, present and future. On the 20th anniversary of the world’s first endovascular aortic valve implant

M.V. Stan^1, 2, A.V. Khokhlov ^1, 2, O. V. Zelenchuk ^1, 2, B.M. Todurov ^1, 2, N.V. Ponych ^1, 2,M.B. Todurov ², Kh.M. Monastyrska ¹, M.Ya. Slyubyk ¹, Ya.A. Antoniuk ¹

¹ Heart Institute, Ministry of Healthcare of Ukraine, Kyiv, Ukraine
² hupyk National Healthcare University of Ukraine, Kyiv, Ukraine

2022 is a special year for the development of world cardiology: two important events are celebrated, namely the 40th anniversary of the first percutaneous angioplasty performed by Andreas Gruentzig (Switzerland) in September 1977 and the 20th anniversary of the first successful transcatheter aortic valve implantation (TAVI) in humans. Undoubtedly, these two techniques changed the development of the cardiovascular field of medicine for many decades. The spread of aortic stenosis, as the most common acquired heart disease, allows us to understand the importance of the latest methods of its correction. The growing prevalence of use and changes in indications for this operation require the collaboration of specialists in various specialties: cardiologists, cardiac surgeons, anesthesiologists, resuscitators, perfusiologists, rheumatologists, electrophysiologists and others. To implement the method in medical institutions, separate teams of doctors «Heart Team» are created that not only participate in the selection of patients, but also participate in the implementation of TAVI. Gaining experience, creating an optimal design and reducing the diameter of the delivery catheters has led to a reduction in the incidence of complications and the possibility of use in lower risk groups.

Key words: TAVI, aortic valve stenosis, aortic valve implantation.

[PDF]

[References]